Acadia Pharmaceuticals Inc (ACAD)

Total Costs & Expenses

$270.12M

Quarterly · Period ending: · USD

ACAD logo

ACAD Total Costs & Expenses

Latest reported$270.12M
ACAD Quarterly Total Costs & Expenses ($4.13M → $270.12M)
High-resolution chart · PNG

ACAD total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Acadia Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
270,123,000
272,678,000
266,598,000
242,877,000
232,192,000
225,027,000
106,099,000
218,757,000
211,526,000
190,621,000
196,097,000
269,475,000
162,198,000
172,046,000
182,553,000
161,580,000
168,214,000
228,484,000
175,415,000
146,913,000
158,930,000
173,326,000
188,169,000
206,476,000
154,113,000
179,583,000
154,725,000
140,007,000
140,296,000
150,593,000
126,846,000
119,576,000
121,142,000
103,687,000
113,571,000
101,889,000
98,909,000
104,092,000
90,193,000
77,667,000
72,020,000
50,266,000
45,582,000
39,037,000
39,498,000
40,556,000
28,602,000
25,009,000
21,751,000
17,988,000
12,201,000
11,051,000
9,608,000
6,581,000
7,199,000
5,885,000
6,028,000
6,681,000
5,902,000
5,677,000
7,044,000
6,296,000
6,275,000
6,543,000
6,593,000
7,629,000
10,475,000
11,209,000
14,641,000
15,542,000
14,536,000
16,371,000
19,220,000
19,247,000
20,288,000
19,850,000
14,658,000
15,413,000
15,323,000
14,482,000
14,745,000
12,637,000
13,142,900
16,486,000
9,008,300
8,125,400
8,538,800
7,903,800
6,901,000
7,355,900
-21,118,400
0
4,323,600
4,130,700
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.